Dr. Paul Donnelly, from The University of Melbourne in Australia, is conducting research to develop molecular agents that can be used in the diagnosis and treatment of Alzheimer’s. In a conference organized by the MGH Gordon Center, Dr. Donnelly presented his effort to synthesize copper and technetium complexes that can bind Aβ plaques associated with Alzheimer’s disease. Dr. Donnelly also discussed the therapeutic possibilities created by the incorporation of radioactive metal isotopes into tumor targeting peptides.
About the Gordon Center for Medical Imaging:
The Gordon Center for Medical Imaging at Massachusetts General Hospital and Harvard University develops new biomedical imaging technologies used in diagnosis and therapy. In addition to translational research, the Center organizes lectures and symposiums as part of its effort to inspire the public and the scientific community about the latest research topics in medical imaging.